{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:24:48Z","timestamp":1763036688755},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1996,11]]},"DOI":"10.1212\/wnl.47.5.1269","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:24:15Z","timestamp":1336915455000},"page":"1269-1277","update-policy":"http:\/\/dx.doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":24,"title":["Presymptomatic diagnosis of neurofibromatosis 2 using linked genetic markers, neuroimaging, and ocular examinations"],"prefix":"10.1212","volume":"47","author":[{"given":"M.E.","family":"Baser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.-F.","family":"Mautner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.K.","family":"Ragge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nechiporuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.M.","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sainz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.-M.","family":"Pulst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"6","volume":"84","year":"1992","unstructured":"Evans DGR, Huson SM, Donnai D, et al. A clinical study of type 2 neurofibromatosis. Q J Med 1992;84:603-618.","journal-title":"Q J Med"},{"key":"e_1_3_1_3_2","first-page":"8","volume":"29","year":"1992","unstructured":"Evans DGR, Huson SM, Donnai D, et al. A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness and confirmation of maternal transmission effect on severity. J Med Genet 1992;29:841-846.","journal-title":"J Med Genet"},{"key":"e_1_3_1_4_2","first-page":"4","volume":"52","year":"1994","unstructured":"Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 1994;52:450-461.","journal-title":"Am J Med Genet"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90042-O"},{"key":"e_1_3_1_6_2","first-page":"5","volume":"363","year":"1993","unstructured":"Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 1993;363:515-521.","journal-title":"Nature"},{"key":"e_1_3_1_7_2","first-page":"8","volume":"68","year":"1971","unstructured":"Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820-823.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_1_8_2","first-page":"2","volume":"51","year":"1994","unstructured":"Consensus Development Panel. National Institutes of Health Consensus Development Conference Statement on Acoustic Neuroma, December 11-13, 1991. Arch Neurol 1994;51:201-207.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_9_2","first-page":"5","volume":"121","year":"1995","unstructured":"Harsh GR IV, MacCollin M, McKenna MJ, Nadol JB, Ojemann R, Short MP. Molecular genetic screening for children at risk of neurofibromatosis 2 [letter]. Arch Otolaryngol Head Neck Surg 1995;121:590-591.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"e_1_3_1_10_2","first-page":"1","volume":"43","year":"1993","unstructured":"Ruttledge MH, Narod SA, Dumanski JP, et al. Presymptomatic diagnosis for neurofibromatosis 2 with chromosome 22 markers. Neurology 1993;43:1753-1760.","journal-title":"Neurology"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.1.1"},{"key":"e_1_3_1_12_2","first-page":"2","volume":"270","year":"1993","unstructured":"MacCollin M, Mohney T, Trofatter J, Wertelecki W, Ramesh V, Gusella J. DNA diagnosis of neurofibromatosis 2: altered coding sequence of the merlin tumor suppressor in an extended pedigree. JAMA 1993;270:2316-2320.","journal-title":"JAMA"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00214177"},{"key":"e_1_3_1_14_2","first-page":"7","volume":"29","year":"1968","unstructured":"Moyes PD. Familial bilateral acoustic neuroma affecting 14 members from four generations. J Neurosurg 1968;29:78-82.","journal-title":"J Neurosurg"},{"key":"e_1_3_1_15_2","first-page":"9","volume":"33","year":"1993","unstructured":"Mautner VF, Tatagiba M, Guthoff R, Samii M, Pulst SM. Neurofibromatosis 2 in the pediatric age group. Neurosurgery 1993;33:92-96.","journal-title":"Neurosurgery"},{"key":"e_1_3_1_16_2","first-page":"6","volume":"120","year":"1995","unstructured":"Ragge NK, Baser ME, Klein J, et al. Ocular abnormalities in neurofibromatosis 2. Am J Ophthalmol 1995;120:634-641.","journal-title":"Am J Ophthalmol"},{"key":"e_1_3_1_17_2","first-page":"8","volume":"38","year":"1996","unstructured":"Mautner VF, Lindenau M, Baser ME, et al. The neuroimaging and clinical spectrum of neurofibromatosis 2. Neurosurgery 1996;38:880-886.","journal-title":"Neurosurgery"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/20.1.1"},{"key":"e_1_3_1_19_2","first-page":"3","volume":"2","year":"1993","unstructured":"Marineau C, Baron C, Delattre O, Zucman J, Thomas G, Rouleau GA. Dinucleotide repeat polymorphism at the D22S268 locus. Hum Mol Genet 1993;2:336.","journal-title":"Hum Mol Genet"},{"key":"e_1_3_1_20_2","first-page":"2","volume":"2","year":"1993","unstructured":"Sainz J, Kim UJ, Simon M, Nechiporuk A, Pulst S. Microsatellite polymorphism in the neurofibromatosis 2 disease region at the locus D22S430. Hum Mol Genet 1993;2:2203.","journal-title":"Hum Mol Genet"},{"key":"e_1_3_1_21_2","first-page":"2","volume":"7","year":"1994","unstructured":"Gyapay G, Morissette J, Vignal A, et al. The 1993-94 Genethon human genetic linkage map. Nat Genet 1994;7:246-339.","journal-title":"Nat Genet"},{"key":"e_1_3_1_22_2","first-page":"5","volume":"15","year":"1993","unstructured":"Porter JC, Ram KT, Puck JM. Twelve new polymorphic microsatellites on human chromosome 22. Genomics 1993;15:57-61.","journal-title":"Genomics"},{"key":"e_1_3_1_23_2","first-page":"4","volume":"51","year":"1992","unstructured":"Narod SA, Parry DM, Parboosingh J, et al. Neurofibromatosis type 2 appears to be a genetically homogeneous disease. Am J Hum Genet 1992;51:486-496.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.1.3"},{"key":"e_1_3_1_25_2","first-page":"8","volume":"29","year":"1992","unstructured":"Evans DGR, Huson SM, Donnai D. A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling. J Med Genet 1992;29:847-852.","journal-title":"J Med Genet"},{"key":"e_1_3_1_26_2","first-page":"5","volume":"13","year":"1992","unstructured":"Wang Z, Weber JL. Continuous linkage map of human chromosome 14 short tandem repeat polymorphisms. Genomics 1992;13:532-536.","journal-title":"Genomics"},{"key":"e_1_3_1_27_2","first-page":"4","volume":"32","year":"1995","unstructured":"Evans DGR, Bourn D, Wallace A, Ramsden RT, Mitchell JD, Strachan T. Diagnostic issues in a family with late onset type 2 neurofibromatosis. J Med Genet 1995;32:470-474.","journal-title":"J Med Genet"},{"key":"e_1_3_1_28_2","first-page":"1","volume":"13","year":"1992","unstructured":"Egelhoff JC, Bates DJ, Ross JS, Rothner AD, Cohen BH. Spinal MR findings in neurofibromatosis types 1 and 2. AJNR Am J Neuroradiol 1992;13:1071-1077.","journal-title":"AJNR Am J Neuroradiol"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.165.1.7785641"},{"key":"e_1_3_1_30_2","first-page":"4","volume":"107","year":"1993","unstructured":"Evans DGR, Ramsden R, Huson SM, Harris R, Lye R, King TT. Type 2 neurofibromatosis: the need for supraregional care? J Laryngol Otol 1993;107:401-406.","journal-title":"Type 2 neurofibromatosis: the need for supraregional care? J Laryngol Otol"},{"key":"e_1_3_1_31_2","first-page":"9","volume":"74","year":"1991","unstructured":"Baldwin D, King TT, Chevretton E, Morrison AW. Bilateral cerebellopontine angle tumors in neurofibromatosis type 2. J Neurosurg 1991;74:910-915.","journal-title":"J Neurosurg"},{"key":"e_1_3_1_32_2","first-page":"6","volume":"28","year":"1991","unstructured":"Bederson JB, von Ammon K, Wichmann WW, Yasargil MG. Conservative management of patients with acoustic tumors. Neurosurgery 1991;28:646-651.","journal-title":"Neurosurgery"},{"key":"e_1_3_1_33_2","first-page":"6","volume":"25","year":"1992","unstructured":"Nedzelski JM, Schessel DA, Pfleiderer A, Kassel EE, Rowed DW. Conservative management of acoustic neuromas. Otolaryngol Clin North Am 1992;25:691-705.","journal-title":"Otolaryngol Clin North Am"},{"key":"e_1_3_1_34_2","first-page":"1","volume":"104","year":"1994","unstructured":"Strasnick B, Glasscock ME, Haynes D, McMenomey S, Minor LB. The natural history of untreated acoustic neuromas. Laryngoscope 1994;104:1115-1119.","journal-title":"Laryngoscope"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1288\/00005537-199201000-00001"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199301000-00001"},{"key":"e_1_3_1_37_2","first-page":"5","volume":"80","year":"1994","unstructured":"Jaaskelaiene J, Paetau A, Pyykko I, Blomstedt G, Palva T, Troupp H. Interface between the facial nerve and large acoustic neurinomas: immunohistochemical study of the cleavage plane in NF2 and non-NF2 cases. J Neurosurg 1994;80:541-547.","journal-title":"J Neurosurg"},{"key":"e_1_3_1_38_2","first-page":"1","volume":"335","year":"1990","unstructured":"Harper PS, Clarke A. Should we test children for \"adult\" genetic diseases? Lancet 1990;335:1205-1206.","journal-title":"Should we test children for \"adult\" genetic diseases? Lancet"},{"key":"e_1_3_1_39_2","first-page":"1","volume":"57","year":"1994","unstructured":"Working Party of the Clinical Genetics Society. The genetic testing of children. J Med Genet 1994;57:1233-1241.","journal-title":"J Med Genet"},{"key":"e_1_3_1_40_2","first-page":"8","volume":"272","year":"1994","unstructured":"Wertz D, Fanos JH, Reilly PR. Genetic testing for children and adolescents: who decides? JAMA 1994;272:875-881.","journal-title":"Genetic testing for children and adolescents: who decides? JAMA"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320570102"},{"key":"e_1_3_1_42_2","first-page":"4","volume":"50","year":"1992","unstructured":"Billings PR, Kohn MA, de Ceuvas M, Beckwith J, Alper JS, Notowicz MR. Discrimination as a consequence of genetic testing. Am J Hum Genet 1992;50:476-482.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_1_43_2","first-page":"3","volume":"270","year":"1995","unstructured":"Hudson KL, Rothenberg KH, Andrews LB, Kahn MJE, Collins FS. Genetic discrimination and health insurance: an urgent need for reform. Science 1995;270:391-393.","journal-title":"Science"},{"key":"e_1_3_1_44_2","first-page":"3","volume":"56","year":"1995","unstructured":"The Ad Hoc Committee on Genetic Testing\/Insurance Issues. Background statement: genetic testing and insurance. Am J Hum Genet 1995;56:327-331.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_1_45_2","first-page":"2","volume":"319","year":"1988","unstructured":"Wertelecki W, Rouleau GA, Superneau DW, et al. Neurofibromatosis 2: clinical and DNA linkage studies of a large kindred. N Engl J Med 1988;319:278-283.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_46_2","first-page":"8","volume":"3","year":"1994","unstructured":"Bourn D, Carter SA, Mason S, Evans DGR, Strachan T. Germ-line mutations in the neurofibromatosis 2 gene in multiple tumor types. Hum Mol Genet 1994;3:813-816.","journal-title":"Hum Mol Genet"},{"key":"e_1_3_1_47_2","first-page":"4","volume":"95","year":"1995","unstructured":"Kluwe L, Pulst SM, Koppen J, Mautner VF. A 163-bp deletion at the C-terminus of the schwannomin gene associated with variable phenotypes of neurofibromatosis type 2. Hum Genet 1995;95:443-446.","journal-title":"Hum Genet"},{"key":"e_1_3_1_48_2","first-page":"2","volume":"97","year":"1996","unstructured":"Kluwe L, Mautner VF. A missense mutation in the NF2 gene results in moderate and mild clinical phenotypes of neurofibromatosis type 2. Hum Genet 1996;97:224-227.","journal-title":"Hum Genet"},{"key":"e_1_3_1_49_2","first-page":"5","volume":"47","year":"1996","unstructured":"Scoles D, Baser ME, Pulst SM. A missense mutation in the neurofibromatosis 2 gene occurs in patients with mild and severe phenotypes. Neurology 1996;47:544-546.","journal-title":"Neurology"},{"key":"e_1_3_1_50_2","first-page":"2","volume":"98","year":"1996","unstructured":"Mautner VF, Baser ME, Kluwe L. Phenotypic variability in two families with novel splice-site and frameshift NF2 mutations. Hum Genet 1996;98:203-206.","journal-title":"Hum Genet"},{"key":"e_1_3_1_51_2","first-page":"2","volume":"21","year":"1992","unstructured":"Tees D, Lofchy N, Rutka J. Deafness, dysphagia and a middle ear mass in a patient with neurofibromatosis type 2. J Otolaryngol 1992;21:227-229.","journal-title":"J Otolaryngol"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0194-1"},{"key":"e_1_3_1_53_2","first-page":"3","volume":"95","year":"1995","unstructured":"Papi L, de Vitis LR, Vitelli F, et al. Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas. Hum Genet 1995;95:347-351.","journal-title":"Hum Genet"},{"key":"e_1_3_1_54_2","first-page":"2","volume":"43","year":"1993","unstructured":"Pulst SM, Rouleau GA, Marineau C, Fain P, Sieb JP. Familial meningioma is not allelic to neurofibromatosis type 2. Neurology 1993;43:2096-2098.","journal-title":"Neurology"},{"key":"e_1_3_1_55_2","first-page":"5","volume":"64","year":"1996","unstructured":"Baser ME, Ragge NK, Riccardi V, Janus T, Gantz B, Pulst S. Phenotypic variability in monozygotic twins with neurofibromatosis 2. Am J Med Genet 1996;64:563-567.","journal-title":"Am J Med Genet"},{"key":"e_1_3_1_56_2","first-page":"9","volume":"2","year":"1978","unstructured":"Kanter WR, Eldridge R. Evidence of a maternal effect in central neurofibromatosis. Lancet 1978;2:903.","journal-title":"Lancet"},{"key":"e_1_3_1_57_2","first-page":"4","volume":"90","year":"1992","unstructured":"Krawczak M, Reiss J, Cooper DN. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 1992;90:41-54.","journal-title":"Hum Genet"},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0993-2"},{"key":"e_1_3_1_59_2","first-page":"8","volume":"56","year":"1995","unstructured":"Boerkoel CF, Exelbert R, Nicastri C, et al. Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II. Am J Hum Genet 1995;56:887-897.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_1_60_2","first-page":"6","volume":"55","year":"1994","unstructured":"Bourn D, Carter SA, Evans DGR, Goodship J, Coakham H, Strachan T. A mutation in the neurofibromatosis type 2 tumor-suppressor gene, giving rise to widely different clinical phenotypes in two unrelated individuals. Am J Hum Genet 1994;55:69-73.","journal-title":"Am J Hum Genet"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.47.5.1269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T10:16:01Z","timestamp":1711534561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.47.5.1269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,11]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1996,11]]}},"alternative-id":["10.1212\/WNL.47.5.1269"],"URL":"https:\/\/doi.org\/10.1212\/wnl.47.5.1269","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,11]]}}}